Search

Your search keyword '"Heneghan MA"' showing total 257 results

Search Constraints

Start Over You searched for: Author "Heneghan MA" Remove constraint Author: "Heneghan MA"
257 results on '"Heneghan MA"'

Search Results

151. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.

152. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.

153. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.

154. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation.

155. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.

156. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.

158. The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.

159. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.

160. Review article: the modern management of autoimmune hepatitis.

161. Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection.

162. Liver disease in pregnancy.

163. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.

164. Normal neurological outcome in two infants treated with exchange transfusions born to mothers with Crigler-Najjar Type 1 disorder.

165. Spontaneous rupture of hepatocellular carcinoma: a Western experience.

166. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience.

167. Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome.

168. Auxiliary transplantation for acute liver failure: Histopathological study of native liver regeneration.

169. Pregnancy and sexual function in liver transplantation.

170. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.

171. Multiple biomarkers and cardiovascular risk.

172. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.

173. An atypical presentation of cystic fibrosis: a case report.

174. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.

175. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.

176. Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.

177. Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival.

178. Novel approaches to assessing renal function in cirrhotic liver disease.

179. Remission in autoimmune hepatitis: what is it, and can it ever be achieved?

180. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up.

181. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation.

182. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.

183. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre.

184. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study.

185. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C.

186. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients.

187. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.

188. Cost-effectiveness of pharmacotherapy for autoimmune hepatitis.

189. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.

190. Current management of the hepatorenal syndrome.

191. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection.

193. The current status of living donor liver transplantation.

194. Pure red cell aplasia following pegylated interferon alpha treatment.

195. Autoimmunity and the female liver.

196. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.

198. De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant.

199. Fulminant hepatic failure.

200. Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese.

Catalog

Books, media, physical & digital resources